Skip to main content

Post-IPO Equity Health Diagnostics Companies

Explore 50 health diagnostics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
50
Total Funding
$1.9B
Avg Funding
$75.9M
Cities
21

Export 50 Post-IPO Equity Health Diagnostics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
New York, United States
$23.5M
raised

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$240.0M
raised

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$3.3M
raised

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Henderson, United States
$4.6M
raised

VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Princeton, Canada
$15.0M
raised

Optimi Health is a supplier of GMP psychedelic compounds.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Hong Kong, Hong Kong

Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newtown, United States
$7.9M
raised

Solana Company is a traded enterprise for digital asset management and neurotechnology innovation.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$18.0M
raised

Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Delta, Canada
$914K
raised

Grey Matters Health company is focused on developing, in-licensing, and commercializing proprietary innovative.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$4.1M
raised

Medpal is an AI-powered personal health consultant that revolutionizes healthcare management

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$200.4M
raised

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

North York, Canada
$519K
raised

Leveljump Healthcare provides telehealth services for the diagnostic imaging and radiology sectors.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rome, Italy
$2.3M
raised

Cube Labs is the first systematic venture builder in the healthcare technology space in Italy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$57.0M
raised

4DMedical is a global medical technology company, revolutionizing respiratory imaging and ventilation analysis for lung diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$20.0M
raised

Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Helsingborg, Sweden
$2.8M
raised

Qlife is a Danish medical technology company that develops an innovative medical technology platform.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$275.0M
raised

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$135.0M
raised

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$10.0M
raised

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Kirkland, United States
$138.0M
raised

Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 50 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New Haven, United States
$200.0M
raised

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$325.0M
raised

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$125.0M
raised

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Penarth, United Kingdom
$9.4M
raised

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Culver City, United States
$80.0M
raised

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 50 companies

Ready to Connect with Post-IPO Equity Health Diagnostics Startups?

Get verified founder emails, funding details, and company data for 50 post-ipo equity health diagnostics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked